NSETrading Window24 Jun 2026 · 24 Jun 2026, 05:45 pm
Trading Window
Strides Pharma Science Limited · STAR
✦ AI Summary
Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in shares of the Company shall remain closed from July 1, 2026, until 48 hours after declaration of the financial results of the Company for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
STRIDES_24062026174501_SE_Intimation_Closure_of_Trading_Window.pdf
View document text
June 24, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex,
Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai - 400 051.
Scrip Code: 532531 Symbol: STAR
Dear Madam/ Sirs,
Ref: Intimation regarding closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Code
of Conduct for Prohibition of Insider Trading of Strides Pharma Science Limited (“Company”),
we hereby inform you that the Trading Window for dealing in shares of the Company shall remain
closed from July 1, 2026, until 48 hours after declaration of the financial results of the Company
for the quarter ended June 30, 2026.
The date of Board Meeting for declaration of financial results of the Company for the quarter
ended June 30, 2026, will be intimated in due course.
Kindly take the above information on record.
Thanks & Regards
For Strides Pharma Science Limited,
Manjula Ramamurthy
Company Secretary & Compliance Officer
ICSI Membership No. A30515
Strides Pharma Science Limited
CIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000
Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199
corpcomm@strides.com; www.strides.com